Upstream Bio UPB
NASDAQ UPB
$5.04 -0.23 (-4.36%)
At close: Oct 1, 2026 · 4:00 PM EDT

Upstream Bio (UPB) Preferred Stock Liabilities (2023 - 2024)

Updated

Upstream Bio (UPB) reported Preferred Stock Liabilities of $380.87 million for Q3 2024, up 64.9% from $230.94 million a year earlier and unchanged from the prior quarter.

Analysis

Upstream Bio (UPB) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

At the end of FY2023, Upstream Bio posted Preferred Stock Liabilities of $230.94 million.

  • Per Business Quant data, the three quarters before Q3 2024 came in at $380.87 million (Q2 2024), $230.94 million (Q1 2024) and $230.94 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Upstream Bio 288.64 Mn 288.64 Mn -3.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 380.87 Mn
Jun 30, 2024 380.87 Mn
Mar 31, 2024 230.94 Mn
Dec 31, 2023 230.94 Mn
Sep 30, 2023 230.94 Mn
API Access

Upstream Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=UPB&period=max&api_key=YOUR_API_KEY